The four arms of Chinese private equity
The Chinese private equity market has lost a lot of its momentum in the past 12 months, with fundraising and investment dropping significantly, particularly in the latter half of 2012. Renminbi fundraising appears to have ground to a near halt, contributing to a more than 50% year-on-year drop in capital entering China-focused vehicles as a whole. Investment numbers are propped up by one deal – the $3.9 billion private equity tranche that formed part of Alibaba Group’s $7.6 billion buyback from Yahoo.
On the macro side, China has gone through quite a few changes. Economic growth is likely to be the slowest in more than two decades and we are in the midst of a once-in-a-generation leadership transition,...
More on Greater China
Latest News
Singapore-based Timothy Zee leaves PAG
Timothy Zee, a Singapore-based managing director with PAG whose primary responsibilities included deal sourcing and business development, has left the firm after 10 years.
Bertelsmann to invest $500m in India
Bertelsmann India Investments has earmarked USD 500m, provided by its eponymous German parent, for investment in local start-ups. The VC unit’s total deployment since its launch in 2013 is USD 285m.
Entrepreneur First raises $158m, targets SE Asia
UK-headquartered incubator Entrepreneur First (EF) has raised USD 158m, targeted in part at investment in Southeast Asian start-ups and expanding its reach in the region.
CDH exits New Zealand supplements brand to Nestle
CDH Investments has agreed to sell New Zealand-based supplements manufacturer The Better Health Company (TBHC) to Nestlé Health Science for an undisclosed sum.